Authors attempt to establish the impact of alliances, both during Exploration and Exploitation stages in the development of new products. Alliances in exploration stages can be defined as more risky, given its high degree of uncertainty. Authors also wish to demonstrate the negative effect of the size of the company on alliances.
Original Description:
Original Title
1. Exploration and Exploitation Alliances in Biotechnology
Authors attempt to establish the impact of alliances, both during Exploration and Exploitation stages in the development of new products. Alliances in exploration stages can be defined as more risky, given its high degree of uncertainty. Authors also wish to demonstrate the negative effect of the size of the company on alliances.
Authors attempt to establish the impact of alliances, both during Exploration and Exploitation stages in the development of new products. Alliances in exploration stages can be defined as more risky, given its high degree of uncertainty. Authors also wish to demonstrate the negative effect of the size of the company on alliances.
EXPLORATIONA ND EXPLOITATIONA LLIANCES IN BIOTECHNOLOGY:
ASYSTEM OF NEW PRODUCT DEVELOPMENT .FRANK T. ROTHAERMEL and DAVID
L DEEDS. Strat. Mgmt. 7., 25: 201-221 (2004) INTRODUCTION Research question 1. Are there mechanisms by which the Exploration alliances could predict future product that a company wants to develop through a mechanism for determining the areas of development and the general lines of research? 2. Are there mechanisms by which Exploitation alliances could determine new products that a company positioned in the market and sold through a mechanism of strengthening strategies and new marketing networks? Key theoretical perspectives Exploration-Exploitation framework. Developed by March 1991 and perfected by Levinthal and March 1993, explains how companies organize their new technological investments for the various stages of new product development. In the context of the research presented in this paper, the authors attempt to establish the impact of alliances, both during Exploration and Exploitation stage in the development of new products, defining a priori that alliances in Exploration stages can be defined as more risky, given its high degree of uncertainty and that alliances in the steps of Exploitation as less risky and which are closest to the stage of the new product launch. In both cases, in a "normal" approximation and a "positive" approximation. Unaddressed puzzle, controversy, or paradox The evidence from the literature on previous research has shown that alliances are very important for companies because they allow reduce product development times and reduce uncertainty by a mechanism of internalization of new knowledge available which would have no access otherwise. Whereas considers product development phases, it can be considered that there are different types of alliances defined for each stage where the internalization of this new knowledge is facilitated. Research on this topic has focused corporate alliances described in general terms and its effect on the development of products, but not targeted for each phase of development. In this sense, the authors attempt als showed that within firms using alliances phases of exploration and exploitation tend to sell more products than those that do not use and at what time use one or the other. Additionally moderator wish to demonstrate the negative effect of the size of the company and that larger firms have more difficulty sustaining alliances and internalize knowledge. So far this effect has not been shown to partnerships at every stage of product development. METHODS Overall design The authors use data from the biotech industry has-been Identified as the industry With the highest frequency alliance Among several industries Characterized by high alliance activity In this study, drug development processes were used by their degree of uncertainty. A correlation analysis was used to study the effect of each variable. Analysis of the variables: 1. Products on the market = / (Exploitation alliances, Controls). 2. Exploitation alliances = / (Products in development, Controls). 3. Products in development = / (Exploration alliances, Controls). Data and procedures 1. 325 biotechnology firms fully dedicated to human therapeutics listed in BioScan, all firms engaged in Developing That Were in vivo therapeutics, for Their FDA Requirements, where the data products were obtained. 2. Firm listed in BioScan alliances where partners, processes, and products developed areas were identified.
Statistical methods/Limit of your techniques
Correlation : X square statistic for one degree of freedom Evaluation: Normed Fit Index (NFI); Comparative Fit Index (CFI); LISREL Goodness of Fit (GFI); Root Mean Error of Approximation (RMSEA) Limitations Only one industry, Another limitation of this study is that we were only able to study surviving alliances. HYPOTHESES, THEIR THEORETICAL REASONING, AND RESULTS List of hypo, their underlying theoretical reasonings From the available evidence regarding phases of product development, impact of partnerships in business development activities and the definition of exploration and exploitation activities in the technological investment, the authors propose that within the phases of product development partnerships are important because exploration of internment by a mechanism of new knowledge to define new products in development and that this in turn define new exploitation alliances favoring d enuevos positioning products in the market. Hypothesis 1: Alliances exploration define new product developments, which in turn define exploitation alliances predict exploitation alliances and new products on the market. Result: Figure 2, provide support for the proposed new product development path. Hypothesis 1 is accepted. When a company defines areas of technological investment begins to grow and acquire more resources will tend to minimize their risks, thus favoring the projects "in house" over external alliances in order to reduce its dependence on external strategic alliances for marketing products. Hypothesis 2: The product development path from exploration alliances leading to products on the market is moderated by firm size negatively. Result: Figure 2, Hypothesis 2 is accepted. Why one has chosen a specific set of explanatory variables over others Firm's products in development as a count variable of each firm's biotechnology products in development that have successfully entered clinical trials but have not yet reached the market for pharmaceuticals. DISCUSSION How does this study fundamentally change, challenge, or advance scholars understanding? It was shown that there is evidence to establish that the product development lines should start with activities ranging from building alliances,, exploration through developing products and exploitation alliances leading to position products in the market. This allows better understand the alliances and new product development under ExplorationExploitation. Additionally it was shown that the size of the company has a negative moderating effect on the development of new partnerships, under ExplorationExploitation, which had not been demonstrated until now. Why is the insight interesting and important in theory and practice? The results obtained in this paper, support the conjecture of transaction cost economics established by Williamson in 1985 regarding the costs of internalization of externally available information and assumptions of hierarchy structure model of optimal capital determined for Myers 1984, regarding establishing a structure that maximizes revenue at lower cost. Future research
1 Specification as to what combination of exploration and exploitation is best when in the
company for superior performance, taking into account the different time horizons for exploration and exploitation modes. 2 Determine how much of each activity Exploration and Exploitation should adopt towards the option of developing "in house" as the search option of external alliances. 3 Investigate the factors that determine the distribution of the income generated between the different organizations involved in the process of product development explorationexploitation 4 Investigate as might mitigate the problems arising in companies resulting from the association in alliances for the development of new products. 5 Assess the validity of this model in various industrial environments.